Glucose stimulates proapoptotic signalling pathways in mesangial cells. Studies focused on inflammatory glomerular injury have demonstrated that removal of apoptotic mesangial cells occurs by neighbouring non-apoptotic mesangial cells. The aim of this study was to define the effect of ambient glucose concentration on mesangial handling of apoptotic cells, and in addition to examine the response made by the mesangial cell. We used a co-culture model in which neutrophils aged overnight to induce apoptosis, or apoptotic mesangial cells, labelled with a fluorescent dye, were added to mesangial cells to study phagocytosis. Exposure of mesangial cells to an ambient glucose concentration of 25 mM D-glucose before addition of apoptotic cells led in an increase in mesangial cell phagocytosis. Ingestion of apoptotic cells was inhibited by blocking avb3 integrin-vitronectin receptor or thrombospondin-1. Furthermore, glucose-dependent stimulation of phagocytosis was inhibited by a blocking antibody to TGF-b1. Co-culture of apoptotic cells with mesangial cells stimulated synthesis of TGF-b1 as compared to freshly isolated neutrophils. Increased TGF-b1 synthesis was dependent on direct contact between the two cell types but was not dependent on phagocytosis of apoptotic cells, as TGF-b1 generation was not affected by inhibition of the thrombospondin-1 pathway. We propose a model in which apoptotic cell binding but not phagocytosis stimulates enhanced mesangial cell TGF-b1 synthesis. Furthermore phagocytosis, which involves the thrombospondin-1 pathway, is uncoupled from binding of apoptotic cells, which stimulated TGF-b1 synthesis.
Diabetic nephropathy is a leading cause of end-stage renal disease, which carries high morbidity and mortality rates in patients with diabetes. The early stages of diabetic nephropathy are characterised by thickening of the glomerular basement membrane and glomerular hypertrophy. Increasing mesangial cell number has been documented in the incipient phase of nephropathy, with a direct correlation between mesangial cell number and albumin excretion rates. 1 This relationship between mesangial cell number is, however, lost in patients with overt nephropathy and proteinuria. In overt nephropathy, expansion of the mesangial matrix, mesangial cell loss and glomerular sclerosis are prominent, associated with proteinuria, hypertension and renal dysfunction. 2, 3 There is clear evidence of a positive relationship between hyperglycaemia and susceptibility to renal disease in diabetes mellitus. Exposure of mesangial cells to conditions of elevated glucose concentration in vitro induces mesangial cells apoptosis. 4, 5 These observations are consistent with loss of mesangial cells through apoptosis, which occurs in experimental diabetic nephropathy. 6 Apoptosis is considered to be a mechanism by which cells are deleted without damaging surrounding tissues, with clearance occurring by swift recognition and ingestion by phagocytes. Much of the work to date on the recognition mechanisms for apoptotic cells and the consequence of phagocytosis has been studied in macrophages, where engulfment of apoptotic cells is thought not only to remove them from the tissues but also to provide protections from local damage resulting from release or discharge of injurious or proinflammatory content. 7 Furthermore, recent studies have shown that, in addition to its role in removing cells before they undergo lysis, ingestion of apoptotic cells by macrophages actively suppresses production of proinflammatory cytokines and chemokines. 8, 9 Intriguingly, this suppressive effect was largely inhibited by TGF-b1 neutralising antibodies and was reproduced by exogenous TGF-b1. Apoptotic cell clearance is therefore believed to represent a critical process in tissue remodelling and resolution of inflammatory injury. Within the glomerulus, mesangial cells, which have undergone apoptosis, are predominantly removed by neighbouring non-apoptotic mesangial cells. 10 Although hyperglycaemia has been implicated in mesangial cell apoptosis, the relationship between hyperglycaemia and mesangial cell handling of apoptotic cells has not been characterised so far. In this study, we have examined the effect of elevated glucose concentration on engulfment of apoptotic cells, and defined the mechanism by which this occurs. In addition, we have examined the functional consequences of interaction between mesangial cells and apoptotic cells with particular emphasis on TGF-b1 generation, which has been implicated as a critical factor promoting renal injury in diabetes.
MATERIALS AND METHODS Reagents
Inhibitors, antibodies and reagents and their sources were as follows: cell culture media, penicillin/streptomycin, L-glutamine, HEPES and hydrocortisone (Life Technologies, Paisley, UK); insulin, transferrin and sodium selenite (Sigma-Aldrich Co. Ltd, Gillingham, UK); fetal bovine serum (Autogen Bioclear UK Ltd, Calne, UK); a-smooth muscle actin antibody, desmin antibody and cytokeratin antibody (DakoCytomation, Ely, UK); CFSE (Cambridge Bioscience, Cambridge, UK); recombinant human TGF-b1 (R&D Systems Europe Ltd, Abingdon, UK); pan-specific TGF-b antibody (R&D Systems Europe Ltd); monoclonal anti-human CD18 antibody (Alexis Biochemicals, Nottingham, UK); RGDS and RGES peptides (Sigma-Alrich); thrombospondin-1 antibody (R&D systems); alamar blue (Biosource UK Ltd, Nivelles, Belgium); Bright-Glot luciferase assay reporter system (Promega, Southampton, UK).
Mesangial Cells
All experiments were performed using spontaneously transformed rat mesangial cell lines. Cells were cultured in a 1:1 ratio of RPMI-1640/Dulbecco's modified Eagle's medium without glucose but supplemented with 10% fetal bovine serum, insulin, transferrin, sodium selenite, penicillin, streptomycin and L-glutamine. Mesangial cells were characterised on the basis of positive staining for a-smooth muscle actin and desmin and negative staining for cytokeratin (data not shown).
Isolation of Neutrophils and Induction of Apoptosis
Neutrophils were isolated from fresh, citrated blood of healthy volunteers by dextran sedimentation and discontinuous plasma-Percoll density-gradient centrifugation as described previously. 10, 11 Cell number was determined with a Coulter Counter (Beckman Counter). High polymorphic neutrophil (PMN) yield was determined by cytospin preparations. Apoptosis was induced by 'ageing' the neutrophils. 11 After isolation, the PMNs were incubated overnight in tissue culture medium containing 10% FCS at 371C. The amount of apoptosis was assessed by FACS analysis using annexin-V and propidium iodide (PI) staining (Figure 1a) , as described previously. 12 Viable cells were defined as annexin-V/PI negative, cells in early apoptosis were annexin-V positive and PI negative and cells in late apoptosis/necrosis were annexin-V/PI positive.
FACS Analysis of Phagocytosis
Isolated neutrophils were labelled with 5,6-carboxyfluorescein diacetate succinimidylester (CFSE), a fluorescent green dye. 13 The aged PMNs were resuspended in 10 ml of PBS per 30 Â 10 6 PMNs with 20 ml of CFSE (stock 5 mM in DMSO). After 10 min incubation in the dark at room temperature, the uptake of the fluorescent cell stain was inhibited by addition of 200 ml FCS. The cells were centrifuged (1600 r.p.m., 41C for 7 min) and resuspended in 5 mM glucose medium without FCS for co-culture experiments.
For assessment of phagocytosis, labelled neutrophils were co-cultured with mesangial cells for 3 h. The medium was then removed and the PMNs washed off with gentle agitation in PBS, using a Pasteur pipette, three times. A 600 ml portion of PBS and 100 ml of trypsin were then added to each well and the plates were gently agitated, to detach mesangial cells from the plate and to dislodge any bound PMNs. After 10 min, the trypsin was neutralised by adding 100 ml of FCS. The cell suspension was then centrifuged at 1600 r.p.m. and 41C for 7 min. The cell pellets were resuspended in PBS and analysed immediately for phagocytosis by flow cytometry.
Generation of Apoptotic Mesangial Cells
In order to investigate the applicability of our observations to non-immune cells, and specifically to the question of mesangial cell clearance of apoptotic mesangial cells, we sought to validate an experimental model in which an enriched population of apoptotic mesangial cells could be added to normal mesangial cells and phagocytosis quantified. Apoptotic mesangial cells were prepared by incubation at 371C for 48 h in the presence of 10 mM cyclohexamide in supplementfree medium. Subsequently, the percentage of apoptotic mesangial cells was increased by trypsinisation of the cells and allowing the non-apoptotic cells to adhere to a fresh plate overnight.
TGF-b1 ELISA
The mesangial cells were grown to confluence in 5 mM glucose medium, followed by culture in serum-free medium containing 5 or 25 mM glucose for 48 h. Aged neutrophils were then added to the mesangial cells for 3 h. The medium was removed and the PMNs washed off with gentle agitation in PBS, using a Pasteur pipette, three times. Fresh 5 mM glucose medium was added for 48 h and the concentration of TGF-b1 in this medium was then measured. Total TGF-b1 in the cell culture supernatant was measured by specific 
TGF-b1 Bioactivity
Activity of TGF-b1 was examined by determining the luciferase activity of HK-2 cells transiently transfected with a Smad-responsive promoter construct as we have described previously. 14 Cells were cultured in a 1:1 ratio of Ham's F12/ Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, HEPES, L-glutamine, insulin, transferrin, sodium selenite and hydrocortisone. The Smadresponsive promoter (SBE) 4 -Lux was a gift from Aristidis Moustakas (Ludwig Institute for Cancer Research, Uppsala, Sweden). 15 Conditioned medium was generated by culturing mesangial cells under serum-free conditions in either 5 or 25 mM D-glucose for 48 h, before addition of apoptotic cells for a further 3 h. Subsequently, the medium containing PMNs was removed and replaced with serum-free medium for a further 48 h before collection of the culture medium. Subsequently, conditioned medium was added to cells transfected with the Smad reporter construct 24 h before determining luciferase activity.
Statistical Analysis
Statistical analysis was performed using the unpaired Student's t-test, with a value of Po0.05 considered to represent a significant difference. The data are presented as means7s.d. of n experiments as indicated in the figure legends. For each individual experiment, the mean of duplicate determinations was calculated.
RESULTS

Confirmation of Induction of PMN Apoptosis
Using annexin-V positivity as a marker of apoptosis, FACS analysis confirmed apoptosis in greater than 70% of PMNs following overnight ageing. PI positivity was not significantly different between fresh isolated neutrophils and aged neutrophils (6.1773.3 vs 10.2975.8%), thus excluding significant neutrophil necrosis during generation of apoptotic cells. In order to assess the impact of isolation and overnight ageing on neutrophil activation, cell-surface expression of CD18 in fresh isolated with aged neutrophils was assessed by flow cytometry. Fresh and aged PMNs were incubated in FACS buffer (500 ml PBS, 10 mM EDTA, 15 mM sodiumazide, 1% BSA, pH 7.35) with the primary mouse anti-CD18 antibody (1:1000 dilution, diluted in FACS buffer) for 30 min at 41C. The cells were washed in PBS and incubated with anti-mouse-fluorescein isothiocyanate (FITC)-conjugated antibody (1:100 dilution) for 30 min at 41C before analysis by flow cytometry (Figure 1b) . These data suggest that the method is not in association with significant cell activation, as CD18 expression in the freshly isolated neutrophils was identical to its expression in the aged cells. Uptake of fluorescent dye following in vitro ageing was confirmed by FACS analysis (Figure 1c ). In contrast, if cells were labelled before in vitro ageing, fluorescence intensity was markedly reduced.
Demonstration of Ingestion of Apoptotic PMN by Mesangial Cells
Following labelling of apoptotic neutrophils and co-culture with mesangial cells, uptake of fluorescent apoptotic neutrophils was assessed by flow cytometry. The x-axis was set up to measure cell size (mesangial cells are larger than PMNs) and Glucose, TGF-b and mesangial cell apoptosis T Khera et al the y-axis was set up to measure green fluorescence (only PMNs labelled, therefore any 'labelled' mesangial cells have ingested PMNs) ( Figure 2a ). One issue with flow cytometric assay is the possibility of detection of cell association. In order to exclude this possibility, we compared expression of annexin-V in aged neutrophils, mesangial cells and mesangial cells co-cultured with aged neutrophils following light trypsin treatment as described above. As expected, annexin-V was highly expressed in the aged neutrophils compared to mesangial cells. Following co-culture and trypsin treatment by FACS analysis, expression of annexin-V in co-cultured mesangial cells and aged neutrophils was similar to that of mesangial cells alone ( Figure 2b ). These data therefore suggest that no cell association occurs following trypsin treatment of co-cultured cells. In order to assess the impact of isolation of PMNmesangial cell co-culture on PMN activation, surface expression of CD18 in freshly isolated and aged apoptotic neutrophils co-cultured with mesangial cells was assessed by flow cytometry. No increase in CD18 expression was seen following co-culture of either fresh PMN or apoptotic PMN with mesangial cells (Figure 2c ). Although PMA stimulation of freshly isolated PMA led to increased CD18 expression, stimulation of apoptotic PMN did not alter CD18 expression compared to un stimulated apoptotic PMN, not apoptotic PMN co-cultured with mesangial cells. The data therefore suggest that co-culture of apoptotic PMN does not lead to its activation.
Uptake of Apoptotic Mesangial Cells by Healthy Mesangial Cells
Following the protocol outlined above, and using annexin-V positivity as a marker of apoptosis, FACS analysis confirmed apoptosis of 80% of the non-adherent mesangial cells ( Figure  3a ). These were used in the subsequent 'phagocytosis' experiments. Apoptotic mesangial cells were labelled with CFSE, as described above, and uptake of fluorescent dye was confirmed by FACS analysis (Figure 3b ). For assessment of phagocytosis, labelled apoptotic mesangial cells were cocultured with normal mesangial cells for 3 h. The medium was then removed and the non-internalised apoptotic mesangial cells were washed off with gentle agitation. A 600 ml portion of PBS and 100 ml of trypsin were then added to each well and the plates were gently agitated, to detach the mesangial cells, and phagocytosis was assessed as described above (Figure 3c -e). Internalisation of apoptotic mesangial cells was also confirmed by cytospin analysis. Mesangial cells that had been co-cultured as described were cytospin onto glass slides and examined by microscopy. Small apoptotic cells were visible inside some of the healthy phagocytic mesangial cells, and on examination under fluorescence, these internalised apoptotic cells were shown to fluoresce, demonstrating the uptake of the CFSE-labelled cells (Figure 3e, inset) .
Mesangial Cell Uptake of Apoptotic Cells
Quantification of phagocytosis of apoptotic PMNs by flow cytometry and immunofluorescence confirmed a dosedependent effect of FCS on their uptake (Figure 4a ). Using the phagocytosis assay, pretreatment of confluent mesangial cells with 25 mM D-glucose for 48 h before the addition of apoptotic PMNs led to a significant increase in CFSE-positive mesangial cells compared to pretreatment with 5 mM D-glucose for the same time period, indicating greater uptake of apoptotic PMNs by mesangial cells exposed to high glucose concentrations (Figure 4b ).
TGF-b1 Pretreatment Increased Mesangial Cell Uptake of Apoptotic Cells
Addition of recombinant TGF-b1 to confluent monolayers of mesangial cells for 48 h under serum-free conditions before addition of apoptotic PMNs mimicked the effect of 25 mM D-glucose and led to a significant increase in CFSE-positive mesangial cells at all concentrations of TGF-b1 that we used. Furthermore, addition of a neutralising antibody to TGF-b1 together with 25 mM D-glucose for 48 h before addition of apoptotic PMNs significantly decreased 25 mM D-glucosedependent stimulation of apoptotic PMN engulfment ( Figure 5 ).
Mechanism of Engulfment
Previous reports suggest that binding and ingestion of apoptotic cells by mesangial cells may involve the vitronectin receptor/thrombospondin-1-dependent pathway. 11 Mesangial cells were grown to confluence before addition of 25 mM D-glucose for 48 h. Subsequently, apoptotic PMNs were added in the presence of the RGDS tetrapeptide, an antagonist to the thrombospondin-1-bridged vitronectin integrin recognition mechanism. RGDS significantly inhibited phagocytosis of apoptotic PMNs when added together with apoptotic cells when mesangial cells were pretreated with either 5 or 25 mM D-glucose ( Figure 6 ). Addition of a control RGES peptide had no effect on phagocytosis. Addition of monoclonal antibody to 'bridging' thrombospondin-1 also prevented phagocytosis of apoptotic PMNs by mesangial cells (Figure 6 ).
Phagocytosis of Mesangial Cells
Pretreatment of confluent mesangial cells with 25 mM Dglucose for 48 h before the addition of CFSE-labelled apoptotic mesangial cells led to a significant increase in CFSEpositive phagocytic mesangial cells compared to pretreatment with 5 mM D-glucose for the same time period, suggesting greater uptake of apoptotic mesangial cells by healthy mesangial cells exposed to high glucose concentrations ( Figure  7a ). As with apoptotic neutrophils, addition of apoptotic mesangial cells in the presence of the RGDS tetrapeptide significantly inhibited phagocytosis of the apoptotic mesangial cells (Figure 7b ). In the left-hand panels, the x-axis was set up to measure cell size and the y-axis green fluorescence; in the right-hand panel, the x-axis was set up to measure cell number and the y-axis green fluorescence. Internalisation of apoptotic mesangial cells was also confirmed by cytospin analysis and fluorescent microscopy (e, inset).
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TGF-b1 Synthesis by Mesangial Cells during Co-Culture with Apoptotic Cells
As shown in Figure 8 , mesangial cells co-cultured with apoptotic PMNs for 3 h produced significantly more TGF-b1 as compared to mesangial cells cultured alone or co-cultured with fresh PMNs. Pretreatment of confluent mesangial cells with 25 mM D-glucose had no further stimulatory effect on TGF-b1 generation following addition of either apoptotic or fresh PMNs compared to pretreatment with 5 mM D-glucose. Medium collected from freshly isolated PMNs incubated in tissue culture medium for 3 h, from PMNs following overnight 'ageing' or medium collected following incubation of aged PMN for 3 h in tissue culture medium all contained less than 200 pg/ml of TGF-b1, suggesting that PMNs were not the source of TGF-b1. TGF-b1 is generated in a latent form that may be activated by proteolytic processing of the latent complex, 16, 17 and also by conformation change of the latent complex, which may be mediated by integrin binding. 18 Biological activity of TGF-b1 in the cell culture supernatant following co-culture of mesangial cells with apoptotic PMNs was assessed by determining the luciferase activity of HK-2 cells transiently transfected with a Smad-responsive promoter construct as we have described previously.
14 Mesangial cells were pretreated with 5 or 25 mM D-glucose for 48 h before addition of apoptotic PMNs for a further 3 h. Subsequently, PMNs were removed and after a further 48 h incubation in serum-free medium, the culture medium was collected and added to HK-2 cells transfected with the Smad-responsive reporter construct and luciferase activity was determined. In control experiments, media were collected from mesangial cells cultured in either 5 or 25 mM D-glucose without apoptotic PMNs. In addition, to exclude TGF-b1 activity by apoptotic PMNs, the activity of media collected following overnight ageing of PMNs was quantified. Conditioned medium collected from mesangial cells co-cultured with apoptotic PMNs induced a significant increase in luciferase activity of the promoter construct compared to the controls, confirming that TGF-b1 was generated in its active form ( Figure 9 ). There was no difference in TGF-b1 activity of the co-culture medium collected from mesangial cells pretreated with 5 or 25 mM D-glucose. 
TGF-b1 Synthesis is not Dependent on Internalisation but is Dependent on Binding
To judge whether enhanced TGF-b1 synthesis was dependent on ingestion of apoptotic cells, mesangial cells and apoptotic PMNs were co-cultured for 3 h in the presence or absence of 10% FCS, as internalisation is known to be FCS dependent. Subsequently, the medium was removed and replaced with serum-free medium for a further 48 h before quantitation of TGF-b1. There was no significant difference in the production of TGF-b1 when apoptotic PMNs were added to mesangial cells either in the presence or absence of 10% FCS (Figure 10a ). This suggests that TGF-b1 production occurs independently from internalisation of apoptotic cells. This is further supported by the lack of effect on mesangial cell TGFb1 generation of either RGDS or monoclonal anti-thrombospondin-1 antibody, when added together with apoptotic PMNs (Figure 10b) .
To determine whether the increase in TGF-b1 expression was the result of the release of soluble factors from the apoptotic cells or a result of interaction between the two cell types, two different assays were employed. The effect of apoptotic PMNs on mesangial cell-generated TGF-b1 was assessed by co-culture experiments in which the two cell types were separated by a permeable tissue culture insert (pore size 1.0 mm), and by medium transfer assays. When mesangial cells were grown to confluence on 24-well plates and apoptotic PMNs added to the apical aspect of a tissue culture insert, thus allowing co-culture in the absence of direct cell-cell contact, there was no significant increase in luciferase activity relative to the control value in which Glucose, TGF-b and mesangial cell apoptosis T Khera et al mesangial cells were cultured in the absence of apoptotic PMNs (Figure 11a ). In contrast, there was a significant increase in TGF-b1 production when apoptotic PMNs were added directly onto the mesangial cells below the insert. Similarly, addition of apoptotic PMN-conditioned medium to mesangial cell did not result in a significant increase in TGF-b1 production over the control value (Figure 11b ).
DISCUSSION
Changes in glomerular cell number are an important component of the alterations in glomerular structure associated with development of diabetic nephropathy. Numerous studies have demonstrated that an increase in the ambient glucose concentration to which mesangial cells are exposed directly affects many mesangial cell functions. [19] [20] [21] [22] [23] [24] Landmark studies of Wolf et al 20 demonstrated a biphasic growth response of mesangial cells when they were cultured in high glucose concentration. Initially, there was a transient stimulation of replication for 24-48 h followed by a sustained inhibition after longer incubation. 20 Furthermore, these studies demonstrated that this inhibitory effect was mediated by glucose-induced synthesis of TGF-b1. In addition to regulating mesangial cell proliferation, elevated glucose concentration also stimulates mesangial cell apoptosis. 4, 5 It is accepted that mesangial cells are 'semi-professional' phagocytes, which recognise and ingest apoptotic leucocytes in inflamed glomeruli and that this is an important mechanism that governs resolution of glomerular inflammation. 25 In addition to the removal of inflammatory cells, apoptosis is also responsible for the deletion of excess mesangial cells as the glomerulus recovers from injury. 25 During this process, mesangial cells, that have undergone apoptosis are predominantly removed by neighbouring non-apoptotic mesangial cells. In macrophages, two major recognition pathways have been characterised for phagocytosis of apoptotic PMNs. Phosphatidylserine receptors (PSR) on macrophages can bind to phosphatidylserine exposed on apoptotic cells by loss of membrane asymmetry. 26 In addition, the macrophage avb3 integrin vitronectin receptor cooperates with CD36 to bind thrombospondin-1, which bridges the macrophage to unknown moieties on the apoptotic cell surface. 27, 28 Similar mechanisms have also been proposed for mesangial cell recognition of apoptotic cells, as binding but not phagocytosis of apoptotic cells may be prevented by inhibition of the PSR, 29 whereas the avb3 vitronectin/ thrombospondin-1 mechanism has been implicated in the phagocytosis and ingestion of apoptotic neutrophils. 11 The data demonstrate that mesangial cell pretreatment with 25 mM D-glucose leads to greater ingestion of apoptotic cells. As with previous studies, ingestion of apoptotic cells is dependent on the presence of serum. 13 Furthermore, glucoseenhanced phagocytosis was TGF-b1 dependent. TGF-b1 is a well-established mediator of fibrotic changes associated with diabetic nephropathy in both the glomerulus and interstitium. Glucose-stimulated mesangial cell synthesis and secretion of bioactive TGF-b1 has been well documented. [30] [31] [32] In addition, glucose has been demonstrated to enhance sensitivity to the effects of TGF-b1. 33 Both mechanisms may p=0.004 Figure 9 Co-culture of aged PMNs with mesangial cells stimulates the generation of bioactive TGF-b1. Mesangial cells were pretreated with 5 mM (stippled bars) or 25 mM (solid bars) D-glucose for 48 h before addition of apoptotic cells for a further 3 h. Subsequently, the medium containing PMNs was removed and replaced with serum-free medium for a further 48 h before collection of the culture medium (MC CM þ PMNs) and determination of the biological activity of TGF-b1 by its addition to HK-2 cells transfected with the Smad-responsive luciferase-reporter construct. In control experiments, TGF-b1 was quantified in the supernatant taken from mesangial cells treated in an identical manner with the omission of aged PMNs (MC CM Control). In addition, to exclude TGF-b1 activity by apoptotic cells, the activity of media collected following overnight ageing of PMNs was quantified. In all experiments, luciferase activity was quantified 24 h after the addition of conditioned medium to the transfected HK-2 cells. Results represent means7s.e.m. of three individual experiments.
Glucose, TGF-b and mesangial cell apoptosis T Khera et al therefore contribute to enhanced phagocytosis. The TGF-b1-dependent increase in phagocytosis is consistent with the demonstration in macrophages that proinflammatory cytokines including TGF-b1 potentiate phagocytosis of neutrophils undergoing apoptosis. 34 In order to examine the general applicability of our observations to non-immune cells, and more specifically to clearance of apoptotic mesangial cells by healthy mesangial cells, we have developed an in vitro system that quantitates this. The data demonstrate that as with apoptotic neutrophils, exposure of healthy mesangial cells to Subsequently, aged CFSE-labelled PMNs ( þ 10% FCS) were added for a further 3 h either alone or in the presence of RGDS (100 mM) or antithrombospondin-1 antibody (7 mg/ml) for a further 3 h. After 3 h of co-culture, the medium containing PMNs was removed and replaced with serum-free medium for a further 48 h before quantitation of TGF-b1 in the supernatant by ELISA. In control experiments, TGF-b1 was quantified in the supernatant taken from mesangial cells exposed to serum-free medium only for 48 h. Data represent mean7s.e.m., n ¼ 3. In control experiments, serum-free medium alone was added to a mesangial cell monolayer. After 3 h of co-culture, the medium containing PMNs was removed and replaced with serum-free medium for a further 48 h before quantitation of TGF-b1 in the supernatant by ELISA (a). Conditioned medium from aged PMNs has no effect on TGF-b1 generation (b). Aged PMNs were incubated in tissue culture medium for 3 h. The samples were centrifuged at 1600 r.p.m. and 41C for 7 min and the supernatant was collected. Subsequently, the conditioned medium from apoptotic cells (PMN CM) was added to confluent mesangial cell monolayers for 48 h before quantitation of TGF-b1 by ELISA. In control experiments, serum-free medium alone was added to a mesangial cell monolayer. A positive control was generated by addition of aged PMNs directly to mesangial cells for 3 h in the presence of 10% FCS before removal of PMNs and addition of serum-free medium for a further 48 h and quantitation of TGF-b1. In all experiments, data represent mean7s.e.m., n ¼ 3.
Glucose, TGF-b and mesangial cell apoptosis T Khera et al high glucose concentrations leads to enhanced clearance of apoptotic mesangial cells. This combined with our previous observations suggests that the diabetic state triggers both mesangial cell apoptosis and clearance, which both contribute to hypocellularity. Numerous publications have demonstrated that ingestions of apoptotic cells modulates macrophage function. 9, 35 Much less is known regarding the response elicited by mesangial cells following interaction with apoptotic cells, although interaction between mesangial cells and apoptotic U937 cells has previously been demonstrated to stimulate mesangial cell IL-6 generation. 29 A second key observation is the demonstration that the recognition of apoptotic cells by mesangial cells leads to a stimulation of TGF-b1 generation. The data also demonstrate that direct contact between the two cell types is required to stimulate cytokine generation, as addition of conditioned medium collected from apoptotic neutrophils or separation of the two cell types in a co-culture system using tissue culture inserts failed to stimulate TGF-b1 production. In contrast to phagocytosis of apoptotic cells, TGFb1 generation was not dependent on the presence of serum, suggesting that this process was independent of the engulfment process but rather occurred as a result of cell-surface interactions. This is further supported by the observation that TGF-b1 generation following co-culture of apoptotic cells and mesangial cells is independent of ambient glucose concentration, which is involved in stimulation of phagocytosis. This is consistent with previous studies, which have demonstrated avb3/TSP-mediated mechanisms of phagocytosis of apoptotic neutrophils by mesangial cells that was uncoupled from chemokine secretion. 11 The data in the current study support the role of this recognition pathway in phagocytosis as ingestion of apoptotic cells, both immune and non-immune cells, was inhibited by the RGDS peptide and also an antibody to thrombospondin-1, although the mechanism by which TGF-b1 influences this recognition pathway, however, remains to be defined. A similar thrombospondin-1-mediated potentiation of phagocytosis of apoptotic neutrophils by proinflammtory cytokines has been reported in macrophages. 34 This increase in phagocytosis was not, however, commensurate with alterations in macrophage avb3 or thrombospondin-1, suggesting that other mechanisms of recruitment of this pathway exist, which are as yet unidentified. 34 In our study, neither the RGDS nor the thrombospondin-1 antibody influenced TGF-b1 generation, further supporting the concept that generation of this cytokine is separated from the phagocytosis recognition pathway. We therefore propose that binding of apoptotic cells by mesangial cells may be more important for cytokine generation than ingestion.
Previously, TGF-b1 secretion resulting from interaction of apoptotic cells with macrophages has been associated with suppression of chemokines generation, suggesting that macrophages contribute to the resolution of inflammation not only through apoptotic cell removal but also by actively suppressing inflammatory mediator production. 9 This is further supported by the observation that instillation of apoptotic cells into sites of local inflammation in the lung and peritoneum increased TGF-b1 production and resolution of inflammation in vivo. The increase in apoptotic cells within the glomerulus in diabetes is not a consequence of inflammatory injury, but rather due to the direct stimulation of proapoptotic pathway in mesangial cells. In conclusion, we suggest that although TGF-b1 has potent anti-inflammatory effects, in the context of diabetic nephropathy it is the profibrotic effects of TGF-b1 that predominate. In this context, TGF-b1 therefore has marked disease-promoting rather that disease-limiting effects.
